Additionally, we compared the Oncomine breast panel (Thermofisher) and Qiaseq Human Breast Cancer Panel (Qiagen) by determining the fraction of patients with a detectable somatic mutation in their cfDNA for both panels and determining the concordance between both panels in ER + /HER2- metastatic breast cancer (MBC). This evidence concerns the gene ERBB2 and breast cancer.